Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-24

FDA Approved: ADVIL SINUS CONGESTION AND PAIN — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application to market Advil Sinus Congestion and Pain, a combination ibuprofen and phenylephrine product from Haleon US Holdings…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVIL SINUS CONGESTION AND PAIN (Ibuprofen; phenylephrine hydrochloride)

Snippet

SUPPL AP for ADVIL SINUS CONGESTION AND PAIN (IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE)